Gene · 404663
Papers2,471
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,471
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
Inhibition of MC38 colon cancer growth by multicomponent chemoimmunotherapy with anti-IL-10R antibodies, HES-MTX nanoconjugate, depends on application of IL-12, IL-15 or IL-18 secreting dendritic cell vaccines. | Front Immunol | 2023 | 37545526 | PubTator, text mining | PubMed |
| Skewed X-inactivation is associated with retinal dystrophy in female carriers of RPGR mutations. | Life Sci Alliance | 2023 | 37541846 | PubTator, text mining | PubMed |
| An uninformative NIPT as an early indicator of cri-du-chat due to a chromosomal 5;18 translocation-An atypical presentation of a rare cytogenetic phenomenon. | Clin Case Rep | 2023 | 37529133 | PubTator, text mining | PubMed |
| The role of MSCs and CAR-MSCs in cellular immunotherapy. | Cell Commun Signal | 2023 | 37528472 | PubTator, text mining | PubMed |
| IGF2BP family of RNA-binding proteins regulate innate and adaptive immune responses in cancer cells and tumor microenvironment. | Front Immunol | 2023 | 37503349 | PubTator, text mining | PubMed |
| A structure and knowledge-based combinatorial approach to engineering universal scFv antibodies against influenza M2 protein. | J Biomed Sci | 2023 | 37491224 | PubTator, text mining | PubMed |
| Recent Updates on Viral Oncogenesis: Available Preventive and Therapeutic Entities. | Mol Pharm | 2023 | 37486263 | PubTator, text mining | PubMed |
| Analysis of Several Common APOBEC-type Mutations in Bladder Tumors Suggests Links to Viral Infection. | Cancer Prev Res (Phila) | 2023 | 37477495 | PubTator, text mining | PubMed |
| Neurotoxin-Derived Optical Probes for Biological and Medical Imaging. | Mol Imaging Biol | 2023 | 37468801 | PubTator, text mining | PubMed |
| A novel point-of-care diagnostic prototype system for the simultaneous electrochemiluminescent sensing of multiple traumatic brain injury biomarkers. | Sens Diagn | 2023 | 37465008 | PubTator, text mining | PubMed |
| Development of an Affordable ELISA Targeting the SARS-CoV-2 Nucleocapsid and Its Application to Samples from the Ongoing COVID-19 Epidemic in Ghana. | Mol Diagn Ther | 2023 | 37462793 | PubTator, text mining | PubMed |
| The combined action of the intracellular regions regulates FGFR2 kinase activity. | Commun Biol | 2023 | 37452126 | PubTator, text mining | PubMed |
| Effect of moderate prenatal ethanol exposure on the differential expression of two histamine H3 receptor isoforms in different brain regions of adult rat offspring. | Front Neurosci | 2023 | 37449267 | PubTator, text mining | PubMed |
| Structure and function of a dual antagonist of the human growth hormone and prolactin receptors with site-specific PEG conjugates. | J Biol Chem | 2023 | 37442239 | PubTator, text mining | PubMed |
| Engineered MED12 mutations drive leiomyoma-like transcriptional and metabolic programs by altering the 3D genome compartmentalization. | Nat Commun | 2023 | 37429859 | PubTator, text mining | PubMed |
| Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78. | Proc Natl Acad Sci U S A | 2023 | 37428911 | PubTator, text mining | PubMed |
| Cell Cycle-Related lncRNAs as Innovative Targets to Advance Cancer Management. | Cancer Manag Res | 2023 | 37426392 | PubTator, text mining | PubMed |
| A cohort study reveals different dynamics of SARS-CoV-2-specific antibody formation after Comirnaty and Vaxzevria vaccination. | Vaccine | 2023 | 37407407 | PubTator, text mining | PubMed |
| De novo design of modular protein hydrogels with programmable intra- and extracellular viscoelasticity. | bioRxiv | 2023 | 37398067 | PubTator, text mining | PubMed |
| Comparison of the gut virus communities between patients with Crohn's disease and healthy individuals. | Front Microbiol | 2023 | 37396350 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/404663/papers?page=8